These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7866337)

  • 21. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
    Kahn SR; Solymoss S; Flegel KM
    CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical studies on plasma antithrombin III using an antiserum prepared in our laboratories.
    Cucuianu M; Cristea A; Vonica A; Lascu I
    Med Interne; 1988; 26(3):191-7. PubMed ID: 3187359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen, factor VII, antithrombin III, cholesterol and triglycerides in young men with myocardial infarction and in their sons.
    Jastrzebska M; Torbus-Lisiecka B; Pieczul-Mróz J; Chełstowski K; Naruszewicz M
    Mater Med Pol; 1997; 29(1-4):3-7. PubMed ID: 10214462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation inhibitors in preeclamptic pregnant women.
    Osmanağaoğlu MA; Topçuoğlu K; Ozeren M; Bozkaya H
    Arch Gynecol Obstet; 2005 Mar; 271(3):227-30. PubMed ID: 14735372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased thrombin generation in normal pregnancy.
    Pinto S; Abbate R; Rostagno C; Bruni V; Rosati D; Neri Serneri GG
    Acta Eur Fertil; 1988; 19(5):263-7. PubMed ID: 3252655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
    Probst K; Fijnheer R; Rothova A
    Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Estimation of the correlation between hemostatic parameters and serum lipids in patients with hyperlipidemia type II after simvastatin therapy].
    Broncel M; Marczyk I; Kostka B; Michalska M; Sikora J; Chojnowska-Jezierska J
    Pol Merkur Lekarski; 2007 Jan; 22(127):21-4. PubMed ID: 17477084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma heparin cofactor II, protein C and antithrombin in elective surgery.
    Andersson TR; Berner NS; Larsen ML; Odegaard OR; Abildgaard U
    Acta Chir Scand; 1987 Apr; 153(4):291-6. PubMed ID: 3630527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal activities of protein C, protein S and antithrombin III in young patients with retinal vein occlusion.
    Guareschi G; Viganò D'Angelo S; Foresti V; Bandello F; D'Angelo A
    Haematologica; 1990; 75(5):483-4. PubMed ID: 2151449
    [No Abstract]   [Full Text] [Related]  

  • 30. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Levels of antithrombin III and proteins C in the newborn infant].
    Abad A; Marco Vera P; Mompel A; García Pérez A
    Sangre (Barc); 1989 Apr; 34(2):91-5. PubMed ID: 2756455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The VITA Project: population-based distributions of protein C, antithrombin III, heparin-cofactor II and plasminogen--relationship with physiological variables and establishment of reference ranges.
    Rodeghiero F; Tosetto A
    Thromb Haemost; 1996 Aug; 76(2):226-33. PubMed ID: 8865536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels of coagulation inhibitors, fibrinolytic markers and platelet-derived growth factor-AB in patients with failed hip prosthesis.
    Cenni E; Savarino L; Baldini N; Rotini R; Marinelli A; Mieti M; Giunti A
    Acta Orthop Scand; 2003 Oct; 74(5):559-64. PubMed ID: 14620976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
    Al-Farra HM; Al-Fahoum SK; Tabbaa MA
    Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High plasma levels of protein C activity and antigen in the nephrotic syndrome.
    Mannucci PM; Valsecchi C; Bottasso B; D'Angelo A; Casati S; Ponticelli C
    Thromb Haemost; 1986 Feb; 55(1):31-3. PubMed ID: 3754658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncoupling of protein C and antithrombin III activity in cerebral ischemia patients associated with cutis marmorata.
    Li TH; Chen TH; Lin HS; Liou CW; Liu JS; Chen SS; Chen WH
    Acta Neurol Taiwan; 2008 Dec; 17(4):233-8. PubMed ID: 19280866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on low protein C-expression in severe sepsis].
    Manekeller S; Hertfelder HJ; von Spiegel T; Hering R; Putensen C; Schroeder S
    Zentralbl Chir; 2005 Aug; 130(4):362-7. PubMed ID: 16103962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein C levels can be forecasted by global haemostatic tests in critically ill patients and predict long-term survival.
    Nilsson G; Astermark J; Lethagen S; Vernersson E; Berntorp E
    Thromb Res; 2005; 116(1):15-24. PubMed ID: 15850604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation.
    Aibiki M; Fukuoka N; Umakoshi K; Ohtsubo S; Kikuchi S
    Shock; 2007 Feb; 27(2):139-44. PubMed ID: 17224787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.